This title slide features "国创汇康" as the main title. The subtitle reads "High-end AI Medical Intelligent Manufacturing Business Plan 2025."

国创汇康

高端AI医疗智造 商业计划书 2025

Source: 国创汇康BP 20251115

This agenda slide, titled "目录," outlines five key topics: market opportunities in AI healthcare, company background, solutions with AI smart manufacturing and digital twins, competitive advantages, and financing needs. Each item includes a brief description highlighting growth potential, core team history, innovative technologies, technological leadership, and investment expectations.

目录

1. 1. 市场机遇

探索AI医疗市场增长潜力与全球需求。

2. 2. 公司背景

介绍国创汇康的核心团队与发展历程。

3. 3. 解决方案

展示AI智能制造与数字孪生创新技术。

4. 4. 竞争优势

突出技术领先与产业链全球视野优势。

5. 5. 融资需求

明确资金用途与投资回报预期。 Source: 国创汇康BP 20251115

This section header slide, titled "市场机遇" (Market Opportunities) and numbered 02, introduces the topic of market potential. Its subtitle states: "AI医疗智造浪潮来袭，全球市场机遇无限," emphasizing the surging wave of AI-driven medical intelligent manufacturing and boundless global opportunities.

市场机遇

02

市场机遇

AI医疗智造浪潮来袭，全球市场机遇无限

Source: 国创汇康BP 20251115

The "市场规模" (Market Size) stats slide highlights key industry figures. It projects the global medical device market exceeding $500B by 2025, China's AI medical sector at 30% annual compound growth, and booming smart manufacturing demand.

市场规模

• $500B+: Global Medical Device Market

2025 exceeds 500 billion USD

• 30%: China AI Medical Growth

Annual compound rate

• Booming: Smart Manufacturing Demand

Explosive market surge 📈 Source: 国创汇康BP 20251115

The slide, titled "Globalized Medical Industry Chain," emphasizes China's core role in global medical intelligent manufacturing. It highlights the supply chain's reach to Europe, America, and Asia-Pacific markets, powered by AI for efficient upgrades and reliable global medical supplies.

全球化医疗产业链

!Image

• 中国占据全球医疗智造核心地位
• 供应链辐射欧美亚太市场
• AI驱动产业链高效升级
• 确保全球医疗供应稳定可靠

Source: Wikipedia: global medical supply chain

This slide serves as a section header titled "公司背景" (Company Background). Its subtitle provides an overview of Guochuang Huikang's strengths as an AI-driven leader in high-end medical intelligent manufacturing.

公司背景

公司背景

国创汇康实力概览：AI驱动高端医疗智造领导者

Source: 《国创汇康BP 20251115》

This slide, titled "Company Introduction," highlights the company's 10-year focus on AI medical device manufacturing. It emphasizes the core team's Tsinghua University background and multiple granted patents.

公司简介

• 专注AI医疗设备智造10年
• 核心团队清华背景
• 已获多项专利授权

Source: 国创汇康BP 20251115

The slide, titled "公司里程碑" (Company Milestones), features an image timeline of key achievements in AI medical manufacturing. It lists the company's founding in 2015, first AI device launch in 2018, digital twin breakthrough in 2022, and global medical chain expansion planned for 2025.

公司里程碑

!Image

• 2015: 公司成立，开启AI医疗智造之旅
• 2018: 首款AI医疗设备上市
• 2022: 数字孪生技术重大突破
• 2025: 全球化医疗产业链布局

Source: Image from Wikipedia article "Timeline of artificial intelligence"

This section header slide, titled "AI-Driven Medical Intelligent Manufacturing Platform," introduces Section 03: Solutions. Its subtitle emphasizes AI empowering smart medical manufacturing through digital twin technology and global supply chain integration.

AI驱动医疗智造平台

03

解决方案

AI赋能智能医疗制造，融合数字孪生技术与全球产业链布局

Source: 国创汇康BP 20251115

The slide "核心技术" highlights the AI Intelligent Manufacturing System, integrating AI with production lines for real-time quality detection, scheduling, and assembly, boosting medical device efficiency by 30% and defects to 0.1%. It also presents the Digital Twin Simulation Platform, using virtual factory models for predictive analysis and maintenance, reducing downtime by 50% and optimizing global medical supply chains.

核心技术

Source: 国创汇康BP 20251115

This slide, titled "Digital Twin Demo," showcases real-time 3D monitoring of production lines and AI-powered predictive maintenance for equipment. It emphasizes seamless IoT integration, data visualization, and boosts to efficiency, quality, and global reach.

数字孪生演示

!Image

• Real-time 3D monitoring of production lines
• AI-powered predictive maintenance for equipment
• Seamless IoT integration and data visualization
• Boosts efficiency quality and global reach

Source: 3D数字孪生模型：实时监控医疗设备生产🤖

This section header slide introduces Section 04 titled "竞争优势" (Competitive Advantage). Its subtitle states "领先全球视野，驱动AI医疗智造创新," highlighting a leading global vision driving AI medical manufacturing innovation.

竞争优势

04

竞争优势

领先全球视野，驱动AI医疗智造创新

Source: 国创汇康BP 20251115

The "Core Competitiveness" slide showcases key stats: 40% cost reduction from AI manufacturing optimization, 50% shorter delivery cycles via digital twin technology, and 90%+ patent coverage for core technologies. These metrics emphasize efficiency gains and intellectual property protection.

核心竞争力

• 40%: 成本降低

AI智能制造优化成效

• 50%: 交付周期缩短

数字孪生技术加速交付

• 90%+: 专利覆盖率

核心技术全面保护

The slide outlines a technology roadmap timeline for AI-driven medical manufacturing advancements. Key milestones include the AI platform launch in 2023, digital twin deployment in 2024, and global expansion in 2025.

技术路线图

2023: AI平台上线 AI平台正式上线，推动医疗智造智能化转型，提供高效解决方案。 2024: 数字孪生部署 部署数字孪生技术，实现生产全流程模拟优化与智能决策。 2025: 全球化扩张 启动全球化扩张，构建AI驱动的国际医疗产业链布局。

Source: 国创汇康BP 20251115

This slide serves as the section header for "Financing Needs" (section 05). It includes the subtitle "Co-create the future, join hands to build a global ecosystem for AI medical manufacturing."

融资需求

05

融资需求

共创未来，携手构建AI医疗智造全球生态

Source: 国创汇康BP 20251115

The slide presents an investment plan with a Series A financing round of 50 million yuan. It focuses on capacity expansion and overseas market development, projecting a 5x ROI within 3 years.

投资计划

• A轮融资5000万元
• 产能扩张与海外市场开拓
• 预计3年ROI达5倍

The conclusion slide, titled "Join Guochuang Huikang," calls for partnering in the AI medical manufacturing revolution and thanks the audience for listening. It provides the contact email info@guochuanghuikang.com and urges immediate joining to co-create the future.

加入国创汇康

携手AI医疗智造革命！ 感谢聆听🙏

联系我们：info@guochuanghuikang.com 立即加入，共创未来！

Source: 国创汇康BP 20251115